[1]胡琦,钟世民,汪金玉,等.皮下注射大剂量卵白蛋白诱导小鼠哮喘免疫耐受模型的建立及机制初步研究[J].第三军医大学学报,2016,38(12):1404-1409.
 Hu Qi,Zhong Shimin,Wang Jinyu,et al.Establishment of mouse model of immune tolerance of asthma through subcutaneous injection of high dose of ovalbumin[J].J Third Mil Med Univ,2016,38(12):1404-1409.
点击复制

皮下注射大剂量卵白蛋白诱导小鼠哮喘免疫耐受模型的建立及机制初步研究(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
38卷
期数:
2016年第12期
页码:
1404-1409
栏目:
基础医学
出版日期:
2016-06-30

文章信息/Info

Title:
Establishment of mouse model of immune tolerance of asthma through subcutaneous injection of high dose of ovalbumin
作者:
胡琦钟世民汪金玉范文婷曾靖吴雪婷廖伟
第三军医大学西南医院:儿科,胸心外科实验室
Author(s):
Hu Qi Zhong Shimin Wang Jinyu Fan Wenting Zeng Jing Wu Xueting Liao Wei

Department of Pediatrics, Laboratory of Cardiothoracic Surgery, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China

关键词:
卵白蛋白小鼠模型支气管哮喘免疫耐受
Keywords:
ovalbumin mouse model asthma immune tolerance
分类号:
R-332; R341; R562.25
文献标志码:
A
摘要:

目的      腹部皮下注射大剂量卵白蛋白(ovalbumin ,OVA)建立小鼠哮喘免疫耐受模型并对机制进行初步研究。      方法      选择BALB/c小鼠18只为建模对象,按随机数字表法分为3组:哮喘免疫耐受模型组、哮喘对照组、正常对照组,每组6只。哮喘免疫耐受模型组予10 μg OVA于0、7 d腹腔注射致敏,21~25 d持续5 d予1 mg OVA腹部皮下注射诱导免疫耐受,35、36、37 d予1%OVA雾化激发;哮喘对照组除了省去21~25 d OVA皮下注射诱导免疫耐受外,其余同哮喘免疫耐受模型组;正常对照组使用等量生理盐水致敏及激发。末次激发24 h内检测气道反应性,收集支气管肺泡灌洗液(bronchoalveolar lavage fluid,BALF)计数细胞总数及细胞分类计数,ELISA法检测血清OVA特异性IgE、BALF中IL-4、IFN-γ、IL-10的表达,HE染色观察肺组织病理改变,流式细胞仪检测各组小鼠外周血Treg细胞占CD4+T淋巴细胞百分率情况。      结果      哮喘免疫耐受模型组气道反应性、BALF中嗜酸性粒细胞计数、IL-4水平及血清OVA特异性IgE水平明显低于哮喘对照组,差异有统计学意义(P<0.05);BALF中IL-10明显高于哮喘对照组(P<0.05);而BALF中IFN-γ水平与哮喘对照组差异无统计学意义;同时HE染色发现哮喘免疫耐受模型组肺组织炎症较哮喘对照组明显减轻;流式细胞技术检测发现外周血Treg细胞百分比明显高于哮喘对照组,差异有统计学意义 (P<0.05)。      结论      予致敏小鼠腹部皮下注射大剂量OVA可成功诱导小鼠哮喘免疫耐受形成,Treg及免疫抑制因子IL-10参与了免疫耐受的形成。

Abstract:

Objective      To establish a mouse model of immune tolerance of asthma through subcutaneous injection with high dose of ovalbumin (OVA) in the abdomen and investigate its underlying mechanism.       Methods      With a random number table method, 18 female BALB/c mice were divided into 3 groups: asthmatic immune tolerance model group, asthma control group and normal control group, with 6 mice in each group. The mice in the model group and asthma control group were sensitized with 10 μg OVA by intraperitoneal injection in the abdomen on day 0 and day 7. The mice in the model group induced immune tolerance with 1 mg OVA by subcutaneous injection in the abdomen everyday from day 21 to day 25. Both the model group and asthma control group were challenged with 1% OVA on day 35, day 36 and day 37. The mice in the normal control group was sensitized and challenged with the equal amount of saline. The airway reactivity was detected at 24 h after the last challenge. The enhanced pause (Penh) was measured to evaluate the airway responsiveness with a noninvasive lung functional instrument. Bronchoalveolar lavage fluid (BALF) was collected to count the total cells and eosinophils, and the cytological studies were conducted. The OVA-specific IgE in peripheral blood, and the IL-4, IFN-γ and IL-10 in BALF were detected by enzyme-linked immunosorbent assay (ELISA). The lung tissues were obtained to perform histological analysis by HE staining. The percentage of regulatory T cells in peripheral blood was calculated by flow cytometry.       Results      The airway responsiveness, total cells and eosinophils in BALF of the model group were significantly decreased as compared with the asthma control group (P<0.05). The OVA-specific IgE in peripheral blood and IL-4 in BALF were significantly lower in the model group than that in the asthma control group (P<0.05), and on the contrary, the levels of IL-10 were significantly higher (P<0.05). The levels of IFN-γ had no significant difference. The inflammation of lung tissues was alleviated in the model group. The percentage of regulatory T cells in the model group was significantly higher than that in the asthma control group (P<0.05).       Conclusion      Subcutaneous injection with high dose of OVA can establish the mouse model of asthmatic immune tolerance successfully, which can provide a foundation for further researching the mechanism of asthmatic immune tolerance. Regulatory T cells and IL-10 immunosuppressive factors are involved in the immune tolerance.

参考文献/References:

[1]Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma.[DB/OL]. (2015-04). http: //www.ginasthmas.org/2015/04.pdf.
[2]Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010[J]. Lancet, 2012, 380(9859): 2095-2128.DOI: 10.1016/S0140-6736(12)61728-0
[3]全国儿科哮喘协作组, 中国疾病预防控制中心环境与健康相关产品安全所. 第三次中国城市儿童哮喘流行病学调查[J]. 中华儿科杂志, 2013, 51(10): 729-735. DOI: 10.3760/cma.j.issn.0578-1310.2013.10.003
[4]Papadopoulos N G, Arakawa H, Carlsen K H, et al. International consensus on (ICON) pediatric asthma[J]. Allergy, 2012, 67(8): 976-997. DOI: 10.1111/j.1398-9995.2012.02865.x
[5]Boudousquie C, Pellaton C, Barbier N, et al. CD4+CD25+ T cell depletion impairs tolerance induction in a murine model of asthma[J]. Clin Exp Allergy, 2009, 39(9): 1415-1426. DOI: 10.1111/j.1365-2222.2009.03314.x
[6]Akdis C A, Akdis M. Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens[J]. World Allergy Organ J, 2015, 8(1): 17. DOI: 10.1186/s40413-015-0063-2
[7]Chelladurai Y, Suarez-Cuervo C, Erekosima N, et al. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review[J]. J Allergy Clin Immunol Pract, 2013, 1(4): 361-369. DOI: 10.1016/j.jaip.2013.04.005
[8]Ring J, Gutermuth J. 100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT)[J]. Allergy, 2011, 66(6): 713-724. DOI: 10.1111/j.1398-9995.2010. 02541.x
[9]Liao W, Hu Q, Shen L L, et al. Sublingual Immunotherapy for Asthmatic Children Sensitized to House Dust Mite: A Meta-Analysis[J]. Medicine (Baltimore), 2015, 94(24): e701. DOI: 10.1097/MD.0000000000000701
[10]Yukselen A, Kendirli S G. Role of immunotherapy in the treatment of allergic asthma[J]. World J Clin Cases, 2014, 2(12): 859-865. DOI: 10.12998/wjcc.v2.i12.859
[11]Noviello-Mde L, Batista N V, Dourado L P, et al. Prolonged antigen ingestion by sensitized mice ameliorates airway inflammation[J]. ISRN Allergy, 2011, 2011: 818239. DOI: 10.5402/2011/818239
[12]湛孝东, 姜玉新, 李良怿, 等. 不同浓度卵蛋白变应原对小鼠哮喘模型建立的影响[J]. 中国实验动物学报, 2012, 20(4): 16-20. DOI: 10.3969/j.issn.1005-4847.2012.04.003
[13]Zosky G R, von-Garnier C, Stumbles P A, et al. The pattern of methacholine responsiveness in mice is dependent on antigen challenge dose[J]. Respir Res, 2004, 5: 15. DOI: 10.1186/1465-9921-5-15
[14]Vissers J L, van-Esch B C, Hofman G A, et al. Allergen immunotherapy induces a suppressive memory response mediated by IL-10 in a mouse asthma model[J]. J Allergy Clin Immunol, 2004, 113(6): 1204-1210. DOI: 10.1016/j. jaci.2004.02.041
[15]Taher Y A, Piavaux B J, Gras R, et al. Indoleamine 2, 3-dioxygenase-dependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model[J]. J Allergy Clin Immunol, 2008, 121(4): 983-991.DOI: 10.1016/j.jaci.2007.11.021
[16]宋薇薇, 林小平, 柴若楠. 标准化屋尘螨变应原特异性免疫治疗变应性鼻炎的疗效评估[J]. 临床耳鼻咽喉头颈外科杂志, 2014, 28(5): 300-302. DOI: 10.13201/j.issn.1001-1781.2014.05.006
[17]王红玉, 林小平, 郝创利, 等. 标准化屋尘螨疫苗免疫治疗对变应性支气管哮喘的疗效[J]. 中华结核和呼吸杂志, 2006, 29(10): 679-687.DOI: 10.3760/j: issn: 1001-0939.2006.10.009
[18]Taher Y A, Henricks P A, van-Oosterhout A J. Allergen-specific subcutaneous immunotherapy in allergic asthma: immunologic mechanisms and improvement[J]. Libyan J Med, 2010, 5: 5303. DOI: 10.3402/ljm.v5i0.5303
[19]Shirinbak S, Taher Y A, Maazi H, et al. Suppression of Th2-driven airway inflammation by allergen immunotherapy is independent of B cell and Ig responses in mice[J]. J Immunol, 2010, 185(7): 3857-3865. DOI: 10.4049/jimmunol.0903909
[20]Kowalski M L, Jutel M. Mechanisms of specific immunotherapy of allergic diseases[J]. Allergy, 1998, 53(5): 485-492.
[21]Martin H, Taube C. Regulatory T cells and regulation of allergic airway disease[J]. Am J Clin Exp Immunol, 2012, 1(2): 166-178.
[22]Robinson D S. Regulatory T cells and asthma[J]. Clin Exp Allergy, 2009, 39(9): 1314-1323. DOI: 10.1111/j.1365-2222.2009.03301.x
[23]Akbari O, DeKruyff R H, Umetsu D T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen[J]. Nat Immunol, 2001, 2(8): 725-731. DOI: 10.1038/90667

相似文献/References:

[1]杜晓兰,陈志,尹良军,等.欧几里德几何距离矩阵法对FGFR2 Ser252Trp点突变小鼠头颅形状特征的分析[J].第三军医大学学报,2009,31(08):655.
 DU Xiao-lan,CHEN Zhi,YIN Liang-jun,et al.Skull morphology of mice carrying gain-of-function mutation of FGFR2 Ser252Trp by Euclidean distance matrix analysis[J].J Third Mil Med Univ,2009,31(12):655.
[2]杜晓兰,陈志,尹良军,等.Apert综合征模型小鼠下颌骨形态特点的定量分析[J].第三军医大学学报,2009,31(17):1625.
 DU Xiao-lan,CHEN Zhi,YIN Liang-jun,et al.Quantitative analysis on developmental morphologic changes on mandibles of Apert syndrome mice[J].J Third Mil Med Univ,2009,31(12):1625.
[3]李兰双,胡丽娜.宫颈癌淋巴道转移模型的建立及Prox-1临床意义初探[J].第三军医大学学报,2009,31(16):1585.
 LI Lan-shuang,HU Li-na.Model establishment of cervical cancer lymphatic metastasis and clinical significance of Prox-1[J].J Third Mil Med Univ,2009,31(12):1585.
[4]杨子峰,杨春光,王玉涛,等.从乙型流感病毒流行株中筛选获得鼠肺适应株的研究[J].第三军医大学学报,2014,36(05):446.
 Yang Zifeng,Yang Chunguang,Wang Yutao,et al.Screening of mouse-lung adapted strain from clinical influenza B viruses[J].J Third Mil Med Univ,2014,36(12):446.

更新日期/Last Update: 2016-06-07